Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

10 Tips for Opioid Prescribing

Dennis J. Boyle, MD  |  Issue: December 2014  |  December 1, 2014

Managing the risks associated with pain medications

Editor’s note: Also see “False Assumptions”.

Case Study 1

A 34-year-old male presented to a rheumatologist for treatment and chronic pain. The patient had severe ankylosing spondylitis (AS) and end-stage hip osteoarthritis. Orthopedics was trying to avoid performing a hip replacement on him at such a young age. The rheumatologist was comfortable prescribing opioids and has treated many patients with scheduled drugs. The patient has had chronic pain for many years and has undergone multiple treatments, including physical therapy, steroid injections and many medications. On presentation, the patient was also on methocarbamol and oxycodone/acetaminophen (four times a day). His past history was positive for hypertension and alcohol abuse, although he stated he had not consumed alcohol in the past year. He worked as a laborer.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

On exam, the patient was in moderate distress with his back pain. His blood pressure was elevated at 160/100. Low back and neurologic exam were normal. He had a decreased Schobers of 8 cm. X-rays showed severe AS and osteoarthritis of the right knee. The physician instituted infliximab at 400 mg/month, oxycodone at 10 mg (BID) for pain control and clonazepam for muscle spasm. On a follow-up visit two weeks later, the oxycodone was increased to 30 (BID).

Two days after the follow-up visit, the patient picked up the medicine at a local pharmacy. The next morning, the patient was found unarousable by his roommate and declared dead on scene by paramedics. The cause of death was polysubstance drug overdose with evidence of opioids, benzodiazepines and alcohol on the toxicology screen. A lawsuit was filed against the physician.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Case Study 2

A rheumatologist had been seeing a 65-year-old female patient for years. The patient had severe rheumatoid arthritis and had taken many prednisone courses over the years. She developed an osteoporotic thoracic spine fracture and was eventually prescribed hydrocodone/APAP 5/325, 240 pills a month.

Because of the increased publicity surrounding the opioid epidemic, the physician worried that the patient was getting too much medication. This was only one of a handful of patients in his practice on opioids. As time went on, the patient became increasingly belligerent with the physician’s staff, and he decided to terminate her from his practice. The physician wrote a dismissal letter to the patient. There were several loud and angry phone calls during the next month. Three months later, the physician received a complaint letter from the state medical board. The physician called the risk manager of his medical group and asked, “Did I do anything wrong here?”

Case Analysis

The first case revolves around the issue of responsible prescribing. Was there an adequate assessment of the risk factors for accidental overdose in this patient, and was the therapy appropriate for the patient’s diagnosis? Was there thorough documentation around the risks and benefits of opioids, and were there attempts to wean or use alternative treatments? Were there discussions with the patient about the issues of polypharmacy and concurrent use of alcohol? Was there an opioid agreement and consent in place? If the answers to these questions were documented in a manner that shows reasonable care, then this will be a very defensible case.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:AnalgesicsAxial SpondyloarthritisConditionsDrug UpdatesPain Syndromes Tagged with:Ankylosing SpondylitisBoyleChronic paindruginfliximabopioidPainpatient careprednisoneprescriberheumatologist

Related Articles

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

    Are Opioid Contracts Helpful or Harmful?

    October 18, 2019

    The opioid epidemic in the U.S. has destroyed thousands of lives and torn families apart. According to the Centers for Disease Control and Prevention, an average of 130 people in the U.S. die each day from an opioid overdose. From 1999 to 2017, more than 700,000 died as a result of drug overdoses. In 2017,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences